VORONOI, Inc.
VORONOI, Inc. has 1 licensing announcement in this dataset, dated 2020-10-20.
- Country / operating region
- South Korea
- Ticker
- 310210.KQ
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- voronoi.io
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| ORIC-114 | EGFR / HER2 | small molecule | 查無 | 2020-10-20 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| ORIC-114 | 查無 | — | 查無 | 查無 | 查無 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2020-10-20 | ORIC Pharmaceuticals, Inc. | ORIC-114 | USD 5m | 查無 | 查無 | 查無 | Cash upfront is separated from stock consideration; the headline combined figure is not used as cash upfront. |
| Counterparty | Territory | Royalties |
|---|---|---|
| ORIC Pharmaceuticals, Inc. | Worldwide excluding mainland China, Hong Kong, Macau and Taiwan | 查無 |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無